# Megatrends One Year Later – #30: The Acceleration Paradox – What I Predicted, and What’s Actually Happening
By 

## Article Content
“As change accelerates exponentially, our challenge is to steer this incredible power toward a more humane and hopeful future – rather than increasing the destructive impacts we’ve seen so far!” - Futurist Jim Carroll One year ago, in August 2025, I published Megatrend #30: The Acceleration Paradox as part of my 30 Megatrends series. Time to grade myself. Here's how I framed it in the original post: We live in a time of incredible promise and yet one of terrible peril. We are the most advanced species we have ever been, and yet, we are ultimately capable of not living up to the demands for success that history places upon us. The world is changing at an unprecedented pace, a phenomenon I call the Acceleration Paradox. We are witnessing not just incremental progress but an exponential surge in technological capabilities that presents both incredible opportunities and profound challenges. As of June 2026, Pew Research found 40% of US adults expect AI to have a negative impact on society over the next 20 years, versus just 16% who expect a positive one — even though 59% agree the products themselves offer more benefits than drawbacks, and 52% say those same products make them nervous. The paradox turned concrete this year in an unexpected way: AI-driven demand pushed memory prices up so far that it's no longer profitable to produce the cheap phones that were a real lifeline for low-income consumers in Africa. That's not an abstract risk. That's the destructive impact I warned about, with a receipt attached. But the acceleration side of the ledger kept cashing checks too. CRISPR isn't a lab curiosity anymore — Casgevy is now approved across the US, Canada, the UK, the EU, and several Gulf states for sickle cell disease and beta-thalassemia, with 90% of US patients getting reimbursed access as of early 2026, and the FDA opened a new fast-track pathway in February for custom gene-editing therapies aimed at rare diseases. Agentic AI went from slide-deck buzzword to line item in the same twelve months. Gartner now says 40% of enterprise applications will embed task-specific AI agents by the end of 2026, up from under 5% a year ago, and IDC pegs agentic AI at 10–15% of enterprise IT spending already. The skills turbulence I flagged is showing up in the paycheck: workers with AI skills command wage premiums up to 56% higher than peers, even as the World Economic Forum still projects 22% of jobs disrupted by 2030 — 170 million roles created against 92 million displaced. The compute and biotech curves didn't bend either. The global biotech market is on pace past $2 trillion this year, still tracking toward the $5.71 trillion mark I cited for 2034, and quantum computing pulled its own timeline forward — IBM now says the industry will confirm quantum advantage before the end of 2026, with fault-tolerant systems targeted for 2029. Verdict: The paradox didn't resolve — it just got receipts on both sides. This closes the series the way it should: not with a victory lap, but with the accelerant and the hazard both showing their work.

---
Source: https://jimcarroll.com/2026/09/megatrends-one-year-later-30-the-acceleration-paradox/